Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × Psychotherapy × Clear all

Phase

Phase 2 5 Phase NA 3 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cisplatin 626 Carboplatin 519 Paclitaxel 503 Cyclophosphamide 460 Radiotherapy 459 Docetaxel 419 Fluorouracil 395 Gemcitabine 370 Doxorubicin 349 Capecitabine 322 Dexamethasone 287 Oxaliplatin 254 Leucovorin 243 Vincristine 240 Etoposide 240 pembrolizumab 238 Bevacizumab 233 Rituximab 215 Prednisone 205 Pemetrexed 184 Cytarabine 183 Drug Therapy 174 Methotrexate 155 Trastuzumab 151 Irinotecan 144 Lenalidomide 125 Filgrastim 121 Nivolumab 116 Tamoxifen 112 Chemotherapy, Adjuvant 112

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07290491 2025-12-18

SPC

The Methodist Hospital Research Institute

Phase 3 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡